Calendario de promoción Pieris Pharmaceuticals, Inc.
Horario avanzado
gráfico sencillo
Acerca de la empresa
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin based drug candidate, elarekibep used for the treatment of asthma; and PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis. más detalles| EBITDA | -0.0261 |
|---|---|
| EV/EBITDA | -4.87 |
| IPO date | 2015-04-13 |
| ISIN | US7207951036 |
| Industry | Biotechnology |
| P/BV | 3.37 |
| P/S | 3.74 |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Выручка | 0.0463 |
| Сайт | https://www.pieris.com |
| Цена ао | 0.188 |
| Число акций ао | 0.09006 млрд |
| Cambio de precio por día: | 0% (13.6) |
|---|---|
| Cambio de precio por semana.: | 0% (13.6) |
| Cambio de precio por mes: | -19.19% (16.83) |
| Cambio de precio en 3 meses.: | -15.84% (16.16) |
| Cambio de precio en seis meses: | +58.69% (8.57) |
| Cambio de precio por año: | +7 372.53% (0.182) |
| Cambio de precio en 3 años.: | +296.5% (3.43) |
| Cambio de precio en 5 años.: | +242.57% (3.97) |
| Cambio de precio en 10 años.: | 0% (13.6) |
| Cambio de precio desde principios de año.: | 0% (13.6) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| BVF Inc. | 20609863 | 20.83 |
| Lynx1 Capital Management Lp | 9775849 | 9.88 |
| Citadel Advisors Llc | 1189887 | 1.2 |
| Renaissance Technologies, LLC | 1065007 | 1.08 |
| Blackrock Inc. | 1037747 | 1.05 |
| Acadian Asset Management. LLC | 962358 | 0.97 |
| Vanguard Group Inc | 907390 | 0.92 |
| Geode Capital Management, LLC | 761444 | 0.77 |
| CM Management, LLC | 750000 | 0.76 |
| Northern Trust Corporation | 243592 | 0.25 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Mr. Stephen S. Yoder J.D. | CEO, President & Director | 744.13k | 1976 (49 años) |
| Mr. Thomas Bures | Senior VP, CFO & Treasurer | 487.5k | 1975 (50 años) |
| Maria Kelman | Executive Director of Investor Relations | N/A | |
| Dr. Shane Olwill Ph.D. | Senior VP & Chief Development Officer | 463.91k | 1976 (49 años) |
| Mr. Prompong Chaikul | Chief Supply Chain Officer | N/A | 1987 (38 años) |
DIRECCIÓN: United States, Boston. MA, 225 Franklin Street - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.pieris.com
Sitio web: https://www.pieris.com
